1,3-dipropyl-8-cyclopentylxanthine and hmr 1098

1,3-dipropyl-8-cyclopentylxanthine has been researched along with hmr 1098 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fox, JE; French, RJ; Kanji, HD; Light, PE1
Babatasi, G; Bricard, H; Ducouret, P; GĂ©rard, JL; Haelewyn, B; Hanouz, JL; Khayat, A; Massetti, M; Terrien, X; Yvon, A1

Other Studies

2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and hmr 1098

ArticleYear
Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial KATP channels during metabolic inhibition and recovery.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:14

    Topics: Adenosine; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Benzamides; Calcium; Cell Hypoxia; Cell Line; Cell Survival; Cells, Cultured; Decanoic Acids; Dose-Response Relationship, Drug; Enzyme Activation; Heart Ventricles; Humans; Hydroxy Acids; Ischemic Preconditioning, Myocardial; KATP Channels; Luminescent Proteins; Membrane Potentials; Mitochondria; Myocardium; Oxygen; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Recombinant Fusion Proteins; Sarcolemma; Time Factors; Ventricular Function; Xanthines

2001
Mechanisms of sevoflurane-induced myocardial preconditioning in isolated human right atria in vitro.
    Anesthesiology, 2003, Volume: 99, Issue:1

    Topics: Aged; Anesthetics, Inhalation; ATP-Binding Cassette Transporters; Benzamides; Decanoic Acids; Heart Atria; Humans; Hydroxy Acids; Hypoxia; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isometric Contraction; KATP Channels; Methyl Ethers; Middle Aged; Myocardial Contraction; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Reperfusion Injury; Sarcolemma; Sevoflurane; Xanthines

2003